CTNI-11. A PHASE 1 OPEN-LABEL STUDY OF BRAF INHIBITOR ABM-1310 IN PATIENTS (PTS) WITH RECURRENT BRAF V600-MUTATED PRIMARY CNS TUMORS

Agaricus blazei

OncologyCognition & nerves

SpeciesAlmond Mushroom, ABM

JournalNeuro-oncology

Year2024

Metadata-grounded summary

Article summary

Metadata-grounded summary: This abstract indexes research on Agaricus blazei in Neuro-oncology in 2024. MycoData maps the paper to oncology, cognition & nerves based on its title, species context, article metadata, and study classification.

Citation

(2024). CTNI-11. A PHASE 1 OPEN-LABEL STUDY OF BRAF INHIBITOR ABM-1310 IN PATIENTS (PTS) WITH RECURRENT BRAF V600-MUTATED PRIMARY CNS TUMORS. Neuro-oncology

Open citation